788 related articles for article (PubMed ID: 27002369)
1. Current status of new tuberculosis vaccine in children.
Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
[TBL] [Abstract][Full Text] [Related]
2. A review of clinical models for the evaluation of human TB vaccines.
O'Shea MK; McShane H
Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in tuberculosis vaccines.
Haile M; Källenius G
Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
[TBL] [Abstract][Full Text] [Related]
4. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
Delogu G; Provvedi R; Sali M; Manganelli R
Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis vaccine: A journey from BCG to present.
Fatima S; Kumari A; Das G; Dwivedi VP
Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
[TBL] [Abstract][Full Text] [Related]
8. New tuberculosis vaccines.
Martín Montañés C; Gicquel B
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
[TBL] [Abstract][Full Text] [Related]
9. Novel vaccine candidates against Mycobacterium tuberculosis.
Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
[TBL] [Abstract][Full Text] [Related]
10. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Tameris M; Geldenhuys H; Luabeya AK; Smit E; Hughes JE; Vermaak S; Hanekom WA; Hatherill M; Mahomed H; McShane H; Scriba TJ
PLoS One; 2014; 9(2):e87340. PubMed ID: 24498312
[TBL] [Abstract][Full Text] [Related]
11. Development of tuberculosis vaccines in clinical trials: Current status.
Méndez-Samperio P
Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis vaccines: Opportunities and challenges.
Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis vaccine: time to look into future.
Chawla S; Garg D; Jain RB; Khanna P; Choudhary S; Sahoo S; Singh I
Hum Vaccin Immunother; 2014; 10(2):420-2. PubMed ID: 24231233
[TBL] [Abstract][Full Text] [Related]
15. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
Horvath CN; Xing Z
Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
[TBL] [Abstract][Full Text] [Related]
16. BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.
Tangie E; Walters A; Hsu NJ; Fisher M; Magez S; Jacobs M; Keeton R
Immunology; 2022 Feb; 165(2):219-233. PubMed ID: 34775598
[TBL] [Abstract][Full Text] [Related]
17. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
18. Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions.
Gowthaman U; Rai PK; Khan N; Jackson DC; Agrewala JN
Trends Mol Med; 2012 Oct; 18(10):607-14. PubMed ID: 22939171
[TBL] [Abstract][Full Text] [Related]
19. Clinical Testing of Tuberculosis Vaccine Candidates.
Hatherill M; Tait D; McShane H
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 28087924
[TBL] [Abstract][Full Text] [Related]
20. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
